Intriguingly, in breast cancer biopsies, the immunohistochemical expression of both total p27 and its pY88 form stratified the tumor sensitivity to Palbociclib, supporting the correlation between pY88-p27, CDK4 activity and Palbociclib sensitivity (86). Here, CDK4 is linked to breast carcinoma.